Drug Patents owned by Purdue Pharma

1. Drug name - INTERMEZZO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7682628 PURDUE PHARMA Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof Feb, 2025

(2 years from now)

US8252809 PURDUE PHARMA Compositions for treating insomnia Feb, 2025

(2 years from now)

US7658945 PURDUE PHARMA Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof Apr, 2027

(4 years from now)

US8242131 PURDUE PHARMA Methods of treating middle-of-the-night insomnia Aug, 2029

(6 years from now)

Drugs and Companies using ZOLPIDEM TARTRATE ingredient

Treatment: Method for treating insomnia; Method of treating middle-of-the-night insomnia

Dosage: TABLET;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
1.75MG TABLET;SUBLINGUAL Discontinued
3.5MG TABLET;SUBLINGUAL Discontinued

2. Drug name - RYZOLT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7988998 PURDUE PHARMA Sustained-release tramadol formulations with 24-hour efficacy Oct, 2023

(1 year, 29 days from now)

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
100MG TABLET, EXTENDED RELEASE;ORAL Discontinued
200MG TABLET, EXTENDED RELEASE;ORAL Discontinued
300MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.